OTC Markets OTCPK - Delayed Quote USD

HORIBA, Ltd. (HRIBF)

Compare
61.03
0.00
(0.00%)
As of April 3 at 4:00:00 PM EDT. Market Open.

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Atsushi Horiba Chairman & Group CEO 2.74M -- 1948
Dr. Masayuki Adachi Ph.D. President, COO & Director 1.2M -- 1962
Mr. Juichi Saito Executive Vice Chairman & Group COO 1.55M -- 1958
Mr. Takashi Nagano Executive Corporate Officer 662.58k -- --
Mr. Tadao Nakamura Corporate Officer -- -- --
Mr. Yasuo Yamashita Corporate Officer & GM of General Administration Division -- -- --
Dr. George Gillespie OBE Executive Corporate Officer -- -- --
Hiroo Chihara Senior Corporate Officer -- -- --
Toshiya Higashino Corporate Officer -- -- --
Hiroyuki Urabe Corporate Officer -- -- --

HORIBA, Ltd.

2 Miyanohigashi
Kisshoin Minami-ku
Kyoto, 601-8510
Japan
81 75 313 8123 https://www.horiba.com/int/
Sector: 
Technology

Description

HORIBA, Ltd. manufactures and sells instruments and systems in worldwide. It operates in five segments: Automotive, Environment/Process, Medical, Semiconductor, and Scientific. The Automotive segment offers engine emission measurement devices; in-use vehicle emission measurement devices; on-board emission measurement devices; in-vehicle exhaust gas measuring devices; driveline test systems; engine test systems; brake test systems; fuel cell test devices; battery test devices; and vehicle development engineering and test engineering services, as well as leases and manages research and development facilities. Its Environment/Process segment provides flue gas analyzers, water quality measuring devices, air pollution monitoring analyzers, environmental radiation measuring instruments, and process measurement equipment. The Medical segment offers hematology and CRP, immunology, clinical chemistry, and blood glucose analyzers, blood cell counters, biochemical testing devices, blood glucose testing devices, as well as coagulation/hemostasis analyzers. Its Semiconductor segment provides mass flow controllers, chemical concentration monitors, semiconductor contaminant inspection equipment, and residual gas analyzer. The Scientific segment offers Raman spectrometers, pH meters, water quality measuring devices, particle size distribution measuring devices, X -ray fluorescence analyzers, elemental analyzers, fluorescence spectroscopy/lifetime spectroscopy, spectrometer/detectors, and gratings. It also engages in the fund management, software development, and automation software for engine. Its products are used in arts, entertainment, and recreation; cosmetics; education, research and development, and government institution; food and beverage; energy solutions; industrials; information technology; life science; materials; water; medical diagnostics; mobility and transportation; and waste management sectors. HORIBA, Ltd. was founded in 1945 and is headquartered in Kyoto, Japan.

Corporate Governance

HORIBA, Ltd.’s ISS Governance QualityScore as of April 1, 2025 is 5. The pillar scores are Audit: 1; Board: 7; Shareholder Rights: 6; Compensation: 1.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

May 12, 2025 at 6:00 AM UTC - May 16, 2025 at 6:00 AM UTC

HORIBA, Ltd. Earnings Date

June 27, 2025 at 12:00 AM UTC

Ex-Dividend Date

Recent Events